Answer
The safety and efficacy of Onivyde pegylated liposomal in children and adolescents aged 18 years or younger have not yet been established, and no data are available.
Sources for this answer
- ONIVYDE pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusionServier Laboratories Limited · emc · SmPC §4.2 Posology and method of administration · Version 13Document updated
Sources checked